GGrantIndex
Sort

261,768 grants matching gene therapy

Biomarkers to Predict Patient Outcomes and Guide Therapies

$960,547
Ann Cashion · National Institute Of Nursing Research · ZIA · FY2016 · NR

Intratumor heterogeneity and tumor evolution

$960,545
Karl Ried · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Global consequences of aneuploidy on gene expression and nuclear architecture

$960,545
Karl Ried · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

IMPULSIVITY, BRAIN FUNCTION & SUBSTANCE ABUSE TREATMENT

$960,515
Frederick Gerard Moeller · University Of Texas Hlth Sci Ctr Houston · P50 · FY2008 · DA

A two-pronged approach to generating novel models of photoreceptor degeneration for regenerative cell therapy

$960,512
Yingbin Fu · Baylor College Of Medicine · U24 · FY2023 · EY

Systems Biology Approaches to Viral Pathogenesis and Immunity

$960,510
Michael G Katze · Oregon Health & Science University · U54 · FY2011 · AI

Targeting Mutant KRAS for Cancer Therapy

$960,504
Said M Sebti · H. Lee Moffitt Cancer Ctr & Res Inst · R35 · FY2016 · CA

GENETIC MODIFICATION OF STRIATED MUSCLES DURING AGING

$960,395
University Of Michigan At Ann Arbor · P01 · FY2002 · AG

Preclinical Testing of Drug Combinations (HDAC, mTOR, CDK and MYC Inhibitors)

$960,380
Beverly Mock · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Tissue Processing-Sequencing Facility

$960,311
Cathy D Vocke · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA

Nox family NADPH oxidases: roles in innate immunity and inflammatory disease

$960,291
Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

Endocrine Responsiveness and Cellular Stress

$960,277
Robert R. Clarke · Georgetown University · U54 · FY2010 · CA

Novel Targets for Vaccine Therapy

$960,254
Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA

Therapeutic targets and novel anticancer agents for endocrine cancers

$960,079
Electron Kebebew · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Identification of Susceptibility Genes for Essential Tremor

$960,071
Lorraine N Clark · Columbia University Health Sciences · R01 · FY2019 · NS

Vaccine and immunotherapy strategies for cancer and viruses causing cancer

$960,045
Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA

Effect of diflunisal (IND68092) on familial amyloidosis

$960,041
Boston University Medical Campus · R01 · FY2005 · NS

From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma

$960,000
Riccardo Dalla-Favera · Columbia University Health Sciences · R35 · FY2020 · CA

Deconstructing aging with senolytic CAR T cells

$960,000
Corina Amor Vegas · Cold Spring Harbor Laboratory · DP5 · FY2025 · OD

From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma

$960,000
Riccardo Dalla-Favera · Columbia University Health Sciences · R35 · FY2017 · CA

Vascular Growth and Regeneration

$960,000
Luisa Iruela-Arispe · Northwestern University At Chicago · R35 · FY2023 · HL

Vascular Growth and Regeneration

$960,000
Luisa Iruela-Arispe · Northwestern University At Chicago · R35 · FY2022 · HL

New and Disruptive Therapeutic Approaches to Target Fundamental Molecular Mechanisms Underlying Atrial Fibrillation

$960,000
Rishi Arora · Northwestern University At Chicago · R35 · FY2023 · HL

Molecular pathways and targeted therapies in human leukemia

$960,000
Adolfo A. Ferrando · Columbia University Health Sciences · R35 · FY2018 · CA

From pathogenesis to new therapeutic targets in Diffuse Large B cell Lymphoma

$960,000
Riccardo Dalla-Favera · Columbia University Health Sciences · R35 · FY2021 · CA